Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma

Endocrinol Metab (Seoul). 2021 Jun;36(3):697-701. doi: 10.3803/EnM.2020.925. Epub 2021 Jun 1.

Abstract

Background: Pheochromocytoma and paraganglioma (PPGL) is diagnosed through biochemical confirmation of excessive catecholamines in urine and plasma. Recent technological developments have allowed us to measure urinary free metanephrines; however, the diagnostic accuracy of these new methods and the diagnostic cutoff values have not been evaluated.

Methods: This is a retrospective study of 595 subjects, including 71 PPGL cases and 524 controls. PPGL was based on pathological confirmation. Subjects with no evidence of PPGL over 2 years were included in the control group.

Results: Urinary free metanephrines yielded similar area under the curve (AUC) to urinary fractionated metanephrines and plasma free metanephrines. However, urinary free normetanephrine yielded a better AUC than did urinary fractionated normetanephrine. The optimal cutoff for urinary free metanephrine and normetanephrine corrected for urinary creatinine yielded 97.2% sensitivity and 98.1% specificity.

Conclusion: Urinary free metanephrines are a reliable method for diagnosing PPGL in Asian populations compared with existing biochemical methods.

Keywords: Metanephrine; Normetanephrine; Paraganglioma; Pheochromocytoma.

MeSH terms

  • Adrenal Gland Neoplasms* / diagnosis
  • Adrenal Gland Neoplasms* / pathology
  • Humans
  • Metanephrine / urine
  • Paraganglioma* / diagnosis
  • Paraganglioma* / pathology
  • Pheochromocytoma* / diagnosis
  • Pheochromocytoma* / pathology
  • Retrospective Studies
  • Sensitivity and Specificity

Substances

  • Metanephrine